News
StockStory.org on MSN2d
MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio DiversificationGlobal pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2025 results , but sales fell by 1.6% year on year to $15.53 ...
Explore key insights from Gladstone Capital's Q2 2025 earnings call, including portfolio updates, robust funding pipelines, and strategic growth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback